Precision Biosciences (DTIL) Payables (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Payables data on file, last reported at $944000.0 in Q1 2026.

• On a quarterly basis, Payables rose 2.16% year-over-year to $944000.0 in Q1 2026; TTM through Mar 2026 was $944000.0, a 2.16% increase from a year earlier, with the FY2025 full-year figure at $296000.0, down 77.44% from the prior year.
• Payables for Q1 2026 stood at $944000.0, up from $296000.0 in the prior quarter.
• Over the last five years, Payables for DTIL reached as high as $3.0 million in Q4 2023 and fell as low as $296000.0 in Q4 2025.
• Historically, Payables has averaged $1.0 million across 5 years, with a median of $944000.0 in 2026.
• Across the five-year window, Payables jumped 354.52% in 2023 and slumped 77.44% in 2025, its largest moves.
• Year by year, Payables stood at $653000.0 in 2022, then jumped by 354.52% to $3.0 million in 2023, then sank by 55.8% to $1.3 million in 2024, then slumped by 77.44% to $296000.0 in 2025, then surged by 218.92% to $944000.0 in 2026.
• Per Business Quant data, the three most recent Payables figures were $944000.0 in Q1 2026, $296000.0 in Q4 2025, and $1.3 million in Q3 2025.